Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-R Ohno Researcher Activity Profile

Research Author Detailed Information 

profile photo of R OhnoR ohno researcher

R Ohno Publication Rate By Year

R Ohno has published 1 paper(s) in 1980, 1 paper(s) in 1995, 1 paper(s) in 1997, 1 paper(s) in 1998, 3 paper(s) in 2000, 1 paper(s) in 2003, 2 paper(s) in 2004, 3 paper(s) in 2007, 4 paper(s) in 2008, for a total of 17 research publications in total.

R R Ohno Author Information

LAST NAME: ohno

FIRST NAME: R

INITIALS: r

AFFILIATION:

Papers

R Ohno's Publication Record

  1. Multidrug resistance P-glycoprotein function of bone marrow hematopoietic cells and the reversal agent effect. Year Published: 2003
  2. Institute of Hematology, Tongji Medical University, Wuhan 430022.
  3. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Year Published: 2004
  4. Department of Pharmacology and Experimental Therapeutics Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto, Japan. takeuchi@mb.kyoto-phu.ac.jp
  5. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia. Year Published: 2007
  6. Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, China.
  7. Some properties and the possible role of intrinsic ATPase of rat liver 80S ribosomes in peptide bond elongation. Year Published: 2000
  8. Institute for Gene Expression, Dobashi Kyoritsu Hospital, Dobashi Matsuyama, Ehime 790-0032, Japan.
  9. An ATPase center of rat liver 30S-5SRNP particles. Year Published: 2000
  10. Institute for Gene Expression, Dobashi Kyoritsu Hospital, Dobashi, Matsuyama, Ehime 790-0032, Japan.
  11. Studies on ATPase(GTPase) intrinsic to E. coli ribosomes. Year Published: 2000
  12. Institute for Gene Expression, Dobashi Kyoritsu Hospital, Dobashi, Matsuyama, Ehime 790-0032, Japan.
  13. Interaction of 5SrRNA-L5 protein complex, methionyl-tRNA, and methionyl-tRNA synthetase in the macromolecular ARS complex. Year Published: 1995
  14. Institute for Gene Expression, Dobashi Kyoritsu Hospital, Ehime.
  15. Further study on association of 5SrRNA-L5 protein complex and methionyl-tRNA to methionyl-tRNA synthetase in the macromolecular aminoacyl-tRNA synthetase complex. Year Published: 1997
  16. Institute for Gene Expression, Dobashi Kyoritsu Hospital, Ehime.
  17. ATPase associated with ribosomal 30S-5SRNP particles and 40S subunits of rat liver. Year Published: 1998
  18. Institute for Gene Expression, Dobashi Kyoritsu Hospital, Matsuyama, Ehime.
  19. Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia: Study of the Japan Adult Leukemia Study Group (JALSG). Year Published: 2007
  20. Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan.
  21. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Year Published: 2004
  22. Department of Pharmacology and Experimental Therapeutics Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto, Japan. takeuchi@mb.kyoto-phu.ac.jp
  23. Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG). Year Published: 2007
  24. Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma 371-0821, Japan. miyawaki@mail.wind.ne.jp
  25. [Clinical clerkship in neurology] Year Published: 2008
  26. Department of Neurology, Saitama Medical University.
  27. Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine. Year Published: 1980
  28. Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. Year Published: 2008
  29. Nagoya University Graduate School of Medicine, Nagoya, Japan. myanada@mdanderson.org
  30. Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. Year Published: 2008
  31. Nagoya University Graduate School of Medicine, Nagoya, Japan. myanada@mdanderson.org
  32. [Clinical clerkship in neurology] Year Published: 2008
  33. Department of Neurology, Saitama Medical University.
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News